Cargando…

Real-world characteristics of T-cell apheresis and clinical response to tisagenlecleucel in B-cell lymphoma

Detalles Bibliográficos
Autores principales:	Cuffel, Alexis, Allain, Vincent, Faivre, Lionel, Di Blasi, Roberta, Morin, Florence, Vercellino, Laetitia, Chevalier, Mathieu F., Desnoyer, Aude, de Jorna, Romain, Madelaine, Isabelle, Parquet, Nathalie, Brignier, Anne C., Thieblemont, Catherine, Larghero, Jerome, Caillat-Zucman, Sophie, Mebarki, Miryam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636323/ https://www.ncbi.nlm.nih.gov/pubmed/35728051 http://dx.doi.org/10.1182/bloodadvances.2022007057

Ejemplares similares

Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma
por: Liévin, Raphaël, et al.
Publicado: (2022)

A major role for CD4(+) T cells in driving cytokine release syndrome during CAR T cell therapy
por: Boulch, Morgane, et al.
Publicado: (2023)

Human umbilical cord-derived mesenchymal stem/stromal cells: a promising candidate for the development of advanced therapy medicinal products
por: Mebarki, Miryam, et al.
Publicado: (2021)

Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells
por: Galtier, Jean, et al.
Publicado: (2022)

Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4(+) CAR T-cell antitumor activity
por: Boulch, Morgane, et al.
Publicado: (2023)

Mesenchymal stem/stromal cell quality control: validation of mixed lymphocyte reaction assay using flow cytometry according to ICH Q2(R1)
por: Nicotra, Tess, et al.
Publicado: (2020)

Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases
por: Mebarki, Miryam, et al.
Publicado: (2021)

Tisagenlecleucel for B-cell cancers
Publicado: (2019)

The use of ICU resources in CAR-T cell recipients: a hospital-wide study
por: Valade, Sandrine, et al.
Publicado: (2022)

Tisagenlecleucel: Hypogammaglobulinaemia and pancytopenia: case report
Publicado: (2021)

Anemia and hemodilution: analysis of a single center cohort based on 2,858 red cell mass measurements
por: Drevon, Louis, et al.
Publicado: (2021)

Tisagenlecleucel: Prolonged neutropenia and thrombocytopenia: case report
Publicado: (2022)

Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma
por: Salles, Gilles, et al.
Publicado: (2022)

Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation
por: Morin-Zorman, Sarah, et al.
Publicado: (2016)

LDL Apheresis and Lp (a) Apheresis: A Clinician’s Perspective
por: Kayikcioglu, Meral
Publicado: (2021)

Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial
por: Fukuhara, Noriko, et al.
Publicado: (2022)

A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma
por: Bachy, Emmanuel, et al.
Publicado: (2022)

Tisagenlecleucel: The First CAR on the Highway to Remission for Acute Lymphoblastic Leukemia
por: Freyer, Craig W.
Publicado: (2018)

Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia
por: Moskop, Amy, et al.
Publicado: (2022)

Apheresis in Neurological Disorders
por: Dorst, Johannes
Publicado: (2020)

Apheresis and Covid-19
por: Griveas, Ioannis
Publicado: (2022)

Control of NK Cell Activation by Immune Checkpoint Molecules
por: Beldi-Ferchiou, Asma, et al.
Publicado: (2017)

HLA-DP diversity is associated with improved response to SARS-Cov-2 vaccine in hematopoietic stem cell transplant recipients
por: Villemonteix, Juliette, et al.
Publicado: (2023)

Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
por: Porter, David, et al.
Publicado: (2018)

Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection
por: Hall, Erin M, et al.
Publicado: (2021)

Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma
por: Kwon, Mi, et al.
Publicado: (2022)

Mucosal-Associated Invariant T Cell Interactions with Commensal and Pathogenic Bacteria: Potential Role in Antimicrobial Immunity in the Child
por: Ghazarian, Liana, et al.
Publicado: (2017)

Therapeutic apheresis in autoimmune diseases
por: Bambauer, Rolf, et al.
Publicado: (2013)

Therapeutic Apheresis in Metabolic Syndrome
por: Voinov, V.A.
Publicado: (2018)

Familial Hypercholesterolemia and Lipoprotein Apheresis
por: Makino, Hisashi, et al.
Publicado: (2019)

Current Role of Lipoprotein Apheresis
por: Thompson, Gilbert, et al.
Publicado: (2019)

Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
por: Porter, D., et al.
Publicado: (2018)

Tisagenlecleucel Model‐Based Cellular Kinetic Analysis of Chimeric Antigen Receptor–T Cells
por: Stein, Andrew M., et al.
Publicado: (2019)

Correction: Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection
Publicado: (2021)

Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel
por: Martín‐Rojas, Reyes Maria, et al.
Publicado: (2022)

Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia
por: Verneris, Michael R., et al.
Publicado: (2021)

Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma
por: Yamasaki-Morita, Makiko, et al.
Publicado: (2022)

Kymriah® (tisagenlecleucel) – An overview of the clinical development journey of the first approved CAR-T therapy
por: Awasthi, Rakesh, et al.
Publicado: (2023)

Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation
por: Noble, Johan, et al.
Publicado: (2021)

In Vitro Expansion of Anti-viral T Cells from Cord Blood by Accelerated Co-cultured Dendritic Cells
por: Kuranda, Klaudia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_so1aepceu4vimhan7sqek3selh